Approval · Notice of Compliance 6728 · 2005
AVONEX: Notice of Compliance 6728
Issued May 12, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6728
- Date
- May 12, 2005
- Company
- Biogen Idec Canada Inc
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication and new strength
- Therapeutic class
- Immunomodulatory agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVONEX | Not yet assigned | — |
| AVONEX | 02267594 | Approved |
Medicinal ingredients
- INTERFERON BETA-1A 30 MCG per ML
- INTERFERON BETA-1A 60 MCG per ML